Observing outcomes of posterior lamellar keratoplasty for eye conditions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients who have undergone posterior lamellar keratoplasty techniques, specifically DSAEK and DMEK, to treat Fuchs' endothelial corneal dystrophy and pseudophakic bullous keratopathy. The study aims to evaluate the prognosis and visual acuity outcomes of these surgical interventions over a specified period. By analyzing data from patients treated at the Metz-Thionville Regional Hospital, researchers will gather insights into the effectiveness and long-term results of these advanced corneal surgeries.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* patients who received a posterior lamellar keratoplasty in Metz-Thionville Regional Hospital between 2012 and 2030

Exclusion Criteria:

* patients refusing to take part in the study

Where it's running

• CHR Metz-Thionville Hopital de Mercy
  Metz, France Recruiting

Study contacts

• Principal investigator: Jean-Marc PERONE, MD — CHR Metz Thionville Hopital de Mercy
• Study coordinator: Arpiné EL NAR, PhD
• Email: projet-recherche-clinique@chr-metz-thionville.fr
• Phone: 0033387557766

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• EO2002 therapy for corneal edema due to endothelial dysfunction

  This trial tests whether a single intracameral injection of EO2002 cells can improve vision and reduce corneal thickness in adults with corneal edema from endothelial dysfunction.

  Recruiting Phase 2 Emmecell · Torrance, California and 9 other locations · NCT07729137

• Polishing the Descemet membrane before endothelial keratoplasty for Fuchs endothelial corneal dystrophy

  This trial tests whether polishing the diseased Descemet membrane before injecting cultured endothelial cells helps improve graft adhesion and outcomes for people with Fuchs endothelial corneal dystrophy.

  Recruiting Centre Hospitalier Universitaire de Saint Etienne · Saint-Etienne, France and 4 other locations · NCT07539012

• Lying on your back after DMEK: 1 day versus 5 days

  This trial sees if lying on your back for five days after DMEK surgery helps the transplant stick better than lying on your back for one day for people with Fuchs endothelial corneal dystrophy or corneal failure.

  Recruiting University Hospital Heidelberg · Heidelberg · NCT07373821

• PVEK corneal implant to treat corneal swelling

  This study will test a PVEK tissue‑engineered corneal implant to see if it is safe and helps people with corneal swelling from Fuchs' endothelial dystrophy or pseudophakic bullous keratopathy who need endothelial keratoplasty.

  Recruiting Phase 1 Precise Bio · Yerevan and 2 other locations · NCT07325097

• VALIDATING the SUCCESS Score to predict need for endothelial keratoplasty after cataract surgery in Fuchs dystrophy

  This study will test whether the SUCCESS Score, with corneal densitometry, can predict which people with Fuchs endothelial corneal dystrophy having cataract surgery will later need endothelial keratoplasty.

  Recruiting Instituto Ramón y Cajal de Investigación Sanitaria · Madrid, Madrid · NCT07265388

• DT-168 for people with Fuchs endothelial corneal dystrophy who are having a corneal transplant

  This study will test whether DT-168 eye drops are safe, well tolerated, and how they act in people with Fuchs endothelial corneal dystrophy who are scheduled for corneal transplant.

  Recruiting at 2 sites Phase 2 Design Therapeutics, Inc. · Indianapolis, Indiana and 1 other locations · NCT07024693

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.